Hepatic steatosis is not always a contraindication for cadaveric liver transplantation

HPB

Volumn 13, Issue 6, 2011, Pages 417-425

  Deroose, Jan P ^a   Kazemier, Geert ^a   Zondervan, Pieter ^a   IJzermans, Jan N M ^a   Metselaar, Herold J ^a   Alwayn, Ian P J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Liver transplantation; Non alcoholic fatty liver disease; Outcome; Steatosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CADAVER; COLD ISCHEMIA; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; GRAFT SURVIVAL; HEART DEATH; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; RISK FACTOR;

EID: 79957558901     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2011.00310.x     Document Type: Article

References (33)

1. Koneru B, Dikdan G. (2002) Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transplantation 73:325-330. (Pubitemid 34174277)
2. Adam R, Reynes M, Johann M, Morino M, Astarcioglu I, Kafetzis I et al. (1991) The outcome of steatotic grafts in liver transplantation. Transplant Proc 23:1538-1540.
3. Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T et al. (1989) Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 47:903-905. (Pubitemid 19139140)
4. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE et al. (1996) Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 62:1246-1251. (Pubitemid 27008548)
5. Afonso RC, Saad WA, Parra OM, Leitao R, Ferraz-Neto BH. (2004) Impact of steatotic grafts on initial function and prognosis after liver transplantation. Transplant Proc 36:909-911. (Pubitemid 38766218)
6. Angele MK, Rentsch M, Hartl WH, Wittmann B, Graeb C, Jauch KW et al. 2008) Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg 195:214-220.
7. Briceno J, Padillo J, Rufian S, Solorzano G, Pera C. (2005) Assignment of steatotic livers by the Mayo model for end-stage liver disease. Transpl Int 18:577-583. (Pubitemid 41726861)
8. Canelo R, Braun F, Sattler B, Klinge B, Lorf T, Ramadori G et al. (1999) Is a fatty liver dangerous for transplantation? Transplant Proc 31:414-415. (Pubitemid 29127509)
9. Crowley H, Lewis WD, Gordon F, Jenkins R, Khettry U. (2000) Steatosis in donor and transplant liver biopsies. Hum Pathol 31:1209-1213.
10. Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME et al. (1997) Use of livers with microvesicular fat safely expands the donor pool. Transplantation 64:248-251. (Pubitemid 27332667)
11. Garcia Urena MA, Colina Ruiz-Delgado F, Moreno Gonzalez E, Jimenez Romero C, Garcia Garcia I, Loinzaz Segurola C et al. (1998) Hepatic steatosis in liver transplant donors: common feature of donor population? World J Surg 22:837-844. (Pubitemid 28322081)
12. Halon A, Patrzalek D, Rabczynski J. (2006) Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population? Transplant Proc 38:193-195.
13. Imber CJ, St Peter SD, Handa A, Friend PJ. (2002) Hepatic steatosis and its relationship to transplantation. Liver Transpl 8:415-423. (Pubitemid 34520769)
14. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. (2007) Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 246:940-946. Discussion 946-8.
15. Montalti R, Nardo B, Bertelli R, Beltempo P, Puviani L, Vivarelli M et al. (2004) Donor pool expansion in liver transplantation. Transplant Proc 36:520-522. (Pubitemid 38534308)
16. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM et al. (1993) Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 55:807-813. (Pubitemid 23122053)
17. Selzner M, Clavien PA. (2001) Fatty liver in liver transplantation and surgery. Semin Liver Dis 21:105-113. (Pubitemid 32240490)
18. Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S et al. (2003) Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 9:500-505. (Pubitemid 36621720)
19. Zamboni F, Franchello A, David E, Rocca G, Ricchiuti A, Lavezzo B et al. (2001) Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 15:53-57. (Pubitemid 32094335)
20. Imber CJ, St Peter SD, Lopez I, Guiver L, Friend PJ. (2002) Current practice regarding the use of fatty livers: a trans-Atlantic survey. Liver Transpl 8:545-549. (Pubitemid 34619087)
21. Alwayn IP, Andersson C, Zauscher B, Gura K, Nose V, Puder M. (2005) Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. Transplantation 79:606-608. (Pubitemid 40365891)
22. Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J et al. (2010) Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 16:943-949.
23. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864-871.
24. D'Alessandro E, Calabrese F, Gringeri E, Valente M. (2010) Frozensection diagnosis in donor livers: error rate estimation of steatosis degree. Transplant Proc 42:2226-2228.
25. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM et al. (2004) Survival following liver transplantation from non-heartbeating donors. Ann Surg 239:87-92. (Pubitemid 38176377)
26. D'Alessandro AM, Hoffmann RM, Knechtle SJ, Odorico JS, Becker YT, Musat A et al. (2000) Liver transplantation from controlled non-heartbeating donors. Surgery 128:579-588.
27. Abt P, Crawford M, Desai N, Markmann J, Olthoff K, Shaked A. (2003) Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation 75:1659-1663. (Pubitemid 36629146)
28. de Vera ME, Lopez-Solis R, Dvorchik I, Campos S, Morris W, Demetris AJ et al. (2009) Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant 9:773-781.
29. Foley DP, Fernandez LA, Leverson G, Chin LT, Krieger N, Cooper JT et al. (2005) Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 242:724-731. (Pubitemid 41567129)
30. Merion RM, Pelletier SJ, Goodrich N, Englesbe MJ, Delmonico FL. (2006) Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg 244:555-562.
31. Baiocchi L, Tisone G, Palmieri G, Rapicetta M, Pisani F, Orlando G et al. (1998) Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation. Liver Transpl Surg 4:441-447. (Pubitemid 28496245)
32. Botha JF, Thompson E, Gilroy R, Grant WJ, Mukherjee S, Lyden ER et al. (2007) Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. Liver Int 27:758-763. (Pubitemid 47062042)
33. Briceno J, Ciria R, Pleguezuelo M, Naranjo A, Sanchez-Hidalgo J, Ruiz-Rabelo J et al. (2007) Contribution of marginal donors to liver transplantation for hepatitis C virus infection. Transplant Proc 39:2297-2299. (Pubitemid 47418216)